[1] FDA Center for Drug Evaluation and Research. Approval Package for: Jevtana. June 17, 2010. Available from: http://www.fda.gov/AboutFDA/CentersOffices/Officeof MedicalProductsandTobacco/CDER/ucm216214.htm [2] Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. CA-Cance J. Clin. 2011, 61, 212-236. [3] Mita, A.C.; Denis, L.J.; Rowinsky, E.K.; DeBono, J.S.; Goetz, A.D.; Ochoa, L.; Forouzesh, B.; Beeram, M.; Patnaik, A.; Molpus, K.; Semiond, D.; Besenval, M.; Tolcher, A.W. Clin. Cancer Res. 2009, 15, 723-730. [4] Sanofi-Aventis. Jevtana prescribing information. June 17, 2010. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/201023lbl.pdf [5] Bradshaw, D.M.; Arceci, R.J. J. Clin. Oncol. 1998, 16, 3674-3690. [6] Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. J. Natl. Cancer Inst. 2000, 92, 1295-1302. [7] Paller, C.J.; Antonarakis, S.E. Drug Des. Devel. Ther. 2011, 5, 117-124. [8] Bouchard, H.; Bourzat, J.D.; Commercon, A. US6372780, 2002. [9] Sun, X.Q.; Chen, X.; Yang, H.T.; Miao, C.B. CN 102285947A. 2011. [10] Zhang, W.Z.; Zhang, A.P.; Wang, Q.Y.; Yin, Z.C.; Huang, W.; Cai, Z.X.; Tong, Z.B.; Gao, S. CN 102311410A. 2012. [11] Chaudhary, A.G.; Rimoldi, J.M.; Kinsgton, D.G.I. J. Org. Chem. 1993, 58, 3798-3799. [12] Gueritte-Voegelein, F.; Senilh, V.; David, B.; Guenard, D.; Potier, P. Tetrahedron. 1986, 42, 4451-4460. [13] Denis, J.N.; Greene, A.E.; Guenard, D.; Gueritte-Voegelein, F.; Mangatal, L.; Potier, P. J. Am. Chem. Soc. 1988, 110, 5917-5919. |